ASTRAZENECA PLC |
Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
| 143,8 EUR | -0,14 % |
|
+1,27 % | +17,89 % |
Resumen de negocios
- ventas de productos (95,6%). Las ventas netas se desglosan por área de tratamiento entre oncología (39,2%), enfermedades cardiovasculares, renales y metabólicas (24,2%), enfermedades respiratorias y autoinmunes (13,9%) y otras (22,7%; enfermedades inflamatorias, neurológicas, gastrointestinales e infecciosas);
- ingresos por colaboración (4,4%).
Las ventas netas se distribuyen geográficamente del siguiente modo: Reino Unido (7,4%), Europa (21,2%), América (45,3%) y África-Asia-Australia (26,1%).
Número de empleados: 89 900
Ventas por actividad
| GBP en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Oncology
37,4
%
| 11 878 | 33,0 % | 13 793 | 37,4 % | +16,12 % |
Cardiovascular, Renal and Metabolism
23,1
%
| 7 459 | 20,7 % | 8 515 | 23,1 % | +14,16 % |
Rare Disease
16,9
%
| 5 726 | 15,9 % | 6 246 | 16,9 % | +9,08 % |
Respiratory and Immunology
13,3
%
| 4 680 | 13,0 % | 4 913 | 13,3 % | +4,97 % |
Alliance
3,1
%
| - | - | 1 149 | 3,1 % | - |
Other Medicines
2,6
%
| 1 319 | 3,7 % | 946 | 2,6 % | -28,29 % |
Vaccines and Immune Therapies
2,2
%
| 3 845 | 10,7 % | 814 | 2,2 % | -78,83 % |
Collaboration
1,3
%
| 1 098 | 3,1 % | 478 | 1,3 % | -56,50 % |
Ventas por región
| GBP en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
United States
39,6
%
| 14 027 | 39,0 % | 14 578 | 39,6 % | +3,93 % |
China
12,8
%
| 4 662 | 12,9 % | 4 724 | 12,8 % | +1,32 % |
Japan
7,9
%
| 3 236 | 9,0 % | 2 928 | 7,9 % | -9,51 % |
United Kingdom
7,4
%
| 2 530 | 7,0 % | 2 709 | 7,4 % | +7,07 % |
Other Rest of Europe
6,8
%
| 2 197 | 6,1 % | 2 502 | 6,8 % | +13,89 % |
Germany
4,6
%
| 1 544 | 4,3 % | 1 689 | 4,6 % | +9,36 % |
Other Asia, Africa and Australasia
4,5
%
| 1 953 | 5,4 % | 1 645 | 4,5 % | -15,77 % |
Sweden
3,7
%
| 1 397 | 3,9 % | 1 371 | 3,7 % | -1,89 % |
Other Americas
3,7
%
| 954 | 2,6 % | 1 354 | 3,7 % | +41,94 % |
France
2,5
%
| 899 | 2,5 % | 927 | 2,5 % | +3,12 % |
Canada
2,1
%
| 947 | 2,6 % | 778 | 2,1 % | -17,82 % |
Spain
1,8
%
| 599 | 1,7 % | 681 | 1,8 % | +13,73 % |
Italy
1,8
%
| 597 | 1,7 % | 654 | 1,8 % | +9,61 % |
Australia
0,9
%
| 464 | 1,3 % | 314 | 0,9 % | -32,32 % |
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 64 | 01/10/12 |
Aradhana Sarin
DFI | Director of Finance/CFO | 50 | 01/08/21 |
Sharon Barr
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/23 |
Regina Danielson
CTO | Chief Tech/Sci/R&D Officer | 60 | - |
Cindy Hoots
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/01/20 |
Jeffrey Pott
CMP | Compliance Officer | - | 01/01/95 |
| Chief Tech/Sci/R&D Officer | - | 18/05/23 | |
Pam Cheng
COO | Chief Operating Officer | 53 | 01/06/15 |
Iskra Reic
PRN | Corporate Officer/Principal | - | 01/01/01 |
Sjoerd Hubben
LAW | General Counsel | - | 01/03/16 |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
Sherilyn McCoy
BRD | Director/Board Member | 66 | 01/10/17 |
Philip Broadley
BRD | Director/Board Member | 63 | 27/04/17 |
| Director/Board Member | 68 | 01/04/99 | |
Marc Dunoyer
PRN | Corporate Officer/Principal | 71 | 01/06/13 |
Andreas Rummelt
BRD | Director/Board Member | 67 | 01/08/21 |
Michel Demaré
CHM | Chairman | 67 | 01/09/19 |
Pascal Soriot
CEO | Chief Executive Officer | 64 | 01/10/12 |
Deborah DiSanzo
BRD | Director/Board Member | 64 | 01/12/17 |
Aradhana Sarin
DFI | Director of Finance/CFO | 50 | 01/08/21 |
Shu Kam Mok
BRD | Director/Board Member | 63 | 01/01/19 |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 1 550 268 075 | 1 498 125 092 ( 96,64 %) | 0 | 96,64 % |
Participaciones
| Nombre | Acciones | % | Valoración |
|---|---|---|---|
| 18 750 000 | 75.00% | 1 403 088 000 $ | |
| 35 043 624 | 9.89% | 938 450 028 $ | |
| 108 923 023 | 37.58% | 552 257 154 $ | |
NIOX GROUP PLC 16.76% | 71 065 878 | 16.76% | 61 626 197 $ |
CELLECTIS S.A. 22.19% | 16 000 000 | 22.19% | 28 362 720 $ |
INNATE PHARMA 9.25% | 7 485 500 | 9.25% | 15 034 327 $ |
| 44 803 | 3.39% | 439 562 $ | |
| 884 956 | 1.99% | 44 248 $ |
Información de la empresa
AstraZeneca PLC
Cambridge Biomedical Campus 1 Francis Crick Avenue
CB2 0AA, Cambridge
+44 20 3749 5000
http://www.astrazeneca.co.uk
Empresas del grupo
| Nombre | Categoría y sector |
|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. |
Miscellaneous Commercial Services
|
Pharmaceuticals: Major
| |
AstraZeneca UK Ltd.
 AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom. |
Miscellaneous Commercial Services
|
R&Q Beta Co. Plc
 R&Q Beta Co. Plc Insurance Brokers/ServicesFinance R&Q Beta Co. Plc provides insurance services. The company was founded in 1994 and is headquartered in Cambridge, the United Kingdom. |
Insurance Brokers/Services
|
AstraZeneca India Pvt Ltd.
 AstraZeneca India Pvt Ltd. Pharmaceuticals: MajorHealth Technology AstraZeneca India Pvt Ltd. operates as a biopharmaceutical company. The company was founded in 1979 and is headquartered in Bangalore, India. |
Pharmaceuticals: Major
|
Astrazeneca Holdings BV
| |
AstraZeneca Share Trust Ltd.
 AstraZeneca Share Trust Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AstraZeneca PLC, AstraZeneca Share Trust Ltd. is a British company that provides business support services. The company is located in the UK. |
Miscellaneous Commercial Services
|
AstraZeneca Employee Share Trust Ltd.
 AstraZeneca Employee Share Trust Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AstraZeneca PLC, AstraZeneca Employee Share Trust Ltd. is a British company that provides business support services. The company is located in the UK. |
Miscellaneous Commercial Services
|
Astrazeneca Treasury BV
|
Ventas por actividad
Ventas por región
Revisiones del BPA
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| +63,59 % | 856 mil M | |
| +38,95 % | 631 mil M | |
| -4,20 % | 359 mil M | |
| +17,51 % | 325 mil M | |
| +8,54 % | 297 mil M | |
| +5,81 % | 234 mil M | |
| +16,48 % | 226 mil M | |
| +15,20 % | 177 mil M | |
| +2,00 % | 165 mil M |
- Bolsa de valores
- Acciones
- Acción AZN
- Acción ZEG
- Empresa AstraZeneca PLC
